Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting Condition

NCT04941196 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Healthy Individuals

Interventions

DRUG: Anplag (Ticagrelor 90 mg)
DRUG: Brilinta (Ticagrelor 90 mg)

Sponsor

University of Karachi

Collaborators

[object Object]